Article
You have full text access to this OnlineOpen article
National institutes of health consensus development conference: Management of hepatitis C: 2002
Article first published online: 10 FEB 2006
DOI: 10.1002/hep.1840360702
Copyright © 2002 American Association for the Study of Liver Diseases
Issue
1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8)
Hepatology
Supplement: National Institutes of Health Consensus Development Conference
Volume 36, Issue Supplement 1, pages S1–S2, November 2002
Additional Information
How to Cite
Seeff, L. B. and Hoofnagle, J. H. (2002), National institutes of health consensus development conference: Management of hepatitis C: 2002. Hepatology, 36: S1–S2. doi: 10.1002/hep.1840360702
Publication History
- Issue published online: 10 FEB 2006
- Article first published online: 10 FEB 2006
References
- 1National Institutes of Health Consensus Development Conference. Management of Hepatitis C. Hepatology 1997; 26: 1S–156S (suppl 1).
- 2, , , , , , , et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556–562.
- 3, , , . The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000; 31: 777–782.Direct Link:
- 4, , , , , , , et al. Peginterferon alfa-2b plus ribavirin compared with interferonalfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001; 358: 958–965.
- 5

1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)